LP
LIGAND PHARMACEUTICALS
LGND· Health Care· BiotechnologyS&P 600
Close · 16/09/2026
275.20
1D
-0.64%52-week range
163.1 – 326.63
Volume
2,99,000.00
Price history
LGND
17/08/2026 to 16/09/2026
O 277.97 H 278.74 L 271.22
1W-4.46%
1M-5.68%
3M+7.82%
6M+30.43%
1Y+66.26%
3Y+332.50%
5Y+222.97%
MAX+273.35%
Fundamentals
as of 16/09/2026- Market cap
- $5.49B
- Shares out
- 19.94M
- P/E (trailing)
- 27.82
- P/E (forward)
- 23.84
- EPS (trailing)
- 9.89
- Beta
- 0.98
- Profit margin
- 67.88%
- P/B
- 5.67
- Return on equity
- 20.38%
SEC financial statements
61 quarterly and 17 annual periods through 30/06/2026.
Details
- Ticker
- LGND
- Index
- SP600
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 16/09/2026.
Tracked by Congress
1 filer · 0 on watchlist · 4 buys · 0 sells · D: 4
- 29/05/2026Gilbert CisnerosBuyLigand Pharmaceuticals Incorporated - Common Stock$1,001–$15,000
- 03/03/2026Gilbert CisnerosBuyLigand Pharmaceuticals Incorporated - Common Stock$1,001–$15,000
- 15/01/2026Gilbert CisnerosBuyLigand Pharmaceuticals Incorporated - Common Stock$1,001–$15,000
- 05/01/2026Gilbert CisnerosBuyLigand Pharmaceuticals Incorporated - Common Stock$1,001–$15,000